, Volume 13, Issue 2, pp 133–140 | Cite as

JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family

  • Susanne A. Schneider
  • Kate E. Marshall
  • Jianfeng Xiao
  • Mark S. LeDouxEmail author
Original Article


We report the clinical, neuropsychological, genetic, and radiological features of a large five-generation African-American kindred from the southern USA presenting with a progressive akinetic-rigid syndrome and severe dementia, but clinically insignificant chorea, due to mutations in junctophillin 3 (JPH3). Overt disease onset was in the mid-20s to late 30s with cognitive decline, REM sleep disturbance, or psychiatric features, followed by development of a levodopa-unresponsive akinetic-rigid motor syndrome. Dystonia and myoclonus were present in some subjects. A bedridden, nonverbal severely akinetic-rigid state developed within 10 to 15 years after onset. CTG repeat expansions ranged from 47 to 53. Imaging revealed generalized cerebral atrophy with severe striatal involvement and putaminal rim hyperintensity. Analysis of our kindred indicates that JPH3 mutations should be considered in the differential diagnosis of early-onset dementia and hypokinetic-rigid syndromes in individuals of African descent. Moreover, chorea may not be overtly manifest at presentation or during significant parts of the disease course.


Dementia Parkinsonism Chorea Huntington's disease JPH3 Putaminal rim African-American 



We thank the family for their participation; Professor Adolfo Bronstein, Imperial College London, for his opinion on the eye movements; and Dr. Amrish Mehta, Charing Cross Hospital, London, for evaluation of the MRI images.


None of the authors have a conflict of interest. Dr. LeDoux serves on the speakers' bureaus for Lundbeck, Merz, and Teva Neuroscience; serves as an advisor for Merz; serves on the Xenazine Advisory Board for Lundbeck, Inc., and the Botulinum Toxin Type A Advisory Board for Allergan; receives research support from the National Institutes of Health, Dystonia Medical Research Foundation, and Merz; and receives royalty payments for Animal Models of Movement Disorders (Elsevier).

Supplementary material


(WMV 2,853 kb)


(WMV 2,964 kb)


(WMV 2,842 kb)

10048_2012_318_MOESM4_ESM.docx (2 mb)
ESM 4 (DOCX 2,015 kb)


  1. 1.
    Margolis RL, O'Hearn E, Rosenblatt A, Willour V, Holmes SE, Franz ML, Callahan C, Hwang HS, Troncoso JC, Ross CA (2001) A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann Neurol 50:373–380Google Scholar
  2. 2.
    Margolis RL, Rudnicki DD, Holmes SE (2005) Huntington's disease like-2: review and update. Acta Neurol Taiwan 14:1–8PubMedGoogle Scholar
  3. 3.
    Greenstein PE, Vonsattel JP, Margolis RL, Joseph JT (2007) Huntington's disease like-2 neuropathology. Mov Disord 22:1416–1423PubMedCrossRefGoogle Scholar
  4. 4.
    Rudnicki DD, Pletnikova O, Vonsattel JP, Ross CA, Margolis RL (2008) A comparison of Huntington disease and Huntington disease-like 2 neuropathology. J Neuropathol Exp Neurol 67:366–374PubMedCrossRefGoogle Scholar
  5. 5.
    Penney JB Jr, Young AB, Shoulson I, Starosta-Rubenstein S, Snodgrass SR, Sanchez-Ramos J, Ramos-Arroyo M, Gomez F, Penchaszadeh G, Alvir J et al (1990) Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5:93–99PubMedCrossRefGoogle Scholar
  6. 6.
    García Ruiz PJ, Hernández J, Cantarero S, Bartolomé M, Sánchez Bernardos V, García de Yébenez J (2002) Bradykinesia in Huntington's disease. A prospective, follow-up study. J Neurol 249:437–440PubMedCrossRefGoogle Scholar
  7. 7.
    Bardien S, Abrahams F, Soodyall H, van der Merwe L, Greenberg J, Brink T, Carr J (2007) A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov Disord 22:2083–2089PubMedCrossRefGoogle Scholar
  8. 8.
    Becker N, Munhoz RP, Raskin S, Cesar W, Teive HA (2007) Non-choreic movement disorders as initial manifestations of Huntington's disease. Arq Neuro-Psiquiatr 65:402–405CrossRefGoogle Scholar
  9. 9.
    Ross CA, Margolis RL (2001) Huntington's disease. Clin Neurosci Res 1:142–152CrossRefGoogle Scholar
  10. 10.
    Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ (2005) Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord 20:1521–1523PubMedCrossRefGoogle Scholar
  11. 11.
    Bech S, Petersen T, Nørremølle A, Gjedde A, Ehlers L, Eiberg H, Hjermind LE, Hasholt L, Lundorf E, Nielsen JE (2010) Huntington's disease like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation. Parkinsonism Relat Disord 16:12–15PubMedCrossRefGoogle Scholar
  12. 12.
    Pasco PM, Ison CV, Muňoz EL, Magpusao NS, Cheng AE, Tan KT, Lo RW, Teleg RA, Dantes MB, Borres R, Maranon E, Demaisip C, Reyes MV, Lee LV (2011) Understanding XDP through imaging, pathology, and genetics. Int J Neurosci 121(Suppl 1):12–17PubMedCrossRefGoogle Scholar
  13. 13.
    Stevanin G, Camuzat A, Holmes SE, Julien C, Sahloul R, Dodé C, Hahn-Barma V, Ross CA, Margolis RL, Durr A, Brice A (2002) CAG/CTG repeat expansions at the Huntington's disease-like 2 locus are rare in Huntington's disease patients. Neurology 58:965–967PubMedGoogle Scholar
  14. 14.
    Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Durr A (2003) Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603PubMedCrossRefGoogle Scholar
  15. 15.
    Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ (2008) Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23:716–720PubMedCrossRefGoogle Scholar
  16. 16.
    Bauer I, Gencik M, Laccone F, Peters H, Weber BH, Feder EH, Weirich H, Morris-Rosendahl DJ, Rolfs A, Gencikova A, Bauer P, Wenning GK, Epplen JT, Holmes SE, Margolis RL, Ross CA, Riess O (2002) Trinucleotide repeat expansions in the junctophilin-3 gene are not found in Caucasian patients with a Huntington's disease-like phenotype. Ann Neurol 51:662PubMedCrossRefGoogle Scholar
  17. 17.
    Rastogi S, Johnson TD, Hoeffel EM, Drewery MP Jr. (2010) The Black population: 2010. U.S. Census Bureau, available at
  18. 18.
    Krause A, Hetem C, Holmes SE, Margolis RL (2005) HDL2 mutations are an important cause of Huntington's disease in patients with African ancestry. J Neurol Neurosurg Psychiatry 76:A16–A26Google Scholar
  19. 19.
    Walker RH, Rasmussen A, Rudnicki D, Holmes SE, Alonso E, Matsuura T, Ashizawa T, Davidoff-Feldman B, Margolis RL (2003) Huntington's disease—like 2 can present as chorea-acanthocytosis. Neurology 61:1002–1004PubMedGoogle Scholar
  20. 20.
    Santos C, Wanderley H, Vedolin L, Pena SD, Jardim L, Sequeiros J (2008) Huntington disease-like 2: the first patient with apparent European ancestry. Clin Genet 73:480–485PubMedCrossRefGoogle Scholar
  21. 21.
    Rodrigues GG, Walker RH, Brice A, Cazeneuve C, Russaouen O, Teive HA, Munhoz RP, Becker N, Raskin S, Werneck LC, Junior WM, Tumas V (2008) Huntington's disease-like 2 in Brazil—report of 4 patients. Mov Disord 23:2244–2247PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Susanne A. Schneider
    • 1
    • 2
  • Kate E. Marshall
    • 3
  • Jianfeng Xiao
    • 3
  • Mark S. LeDoux
    • 3
    • 4
    Email author
  1. 1.Schilling Section of Clinical and Molecular Neurogenetics at the Department of NeurologyUniversity of LubeckLubeckGermany
  2. 2.Department of Clinical Neuroscience, Imperial College LondonCharing Cross CampusLondonUK
  3. 3.Departments of Neurology and Anatomy and NeurobiologyUniversity of Tennessee Health Science CenterMemphisUSA
  4. 4.Department of NeurologyUniversity of Tennessee Health Science CenterMemphisUSA

Personalised recommendations